Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07597759
EARLY_PHASE1

Phase IIT Trial of SNA009

Sponsor: SmartNuclide Biopharma

View on ClinicalTrials.gov

Summary

This clinical trial is a single-center, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics and radiation dosimetry of 68Ga-NODAGA-SNA009 in patients with colorectal cancer.

Official title: A Clinical Study Evaluating the Safety, Tolerability, Biodistribution and Radiation Dose Measurement of 68Ga-NODAGA-SNA009 in Patients With Colorectal Cancer

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2025-10-30

Completion Date

2025-12-31

Last Updated

2026-05-19

Healthy Volunteers

No

Interventions

DRUG

68Ga-NODAGA-SNA009

68Ga-NODAGA-SNA009 is a radiopharmaceutical agents that targets GPA33

Locations (1)

Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality, China